Search
for
Did you mean Endocrine Therapy-Induced Alopecia?
Sort by
Research 30 of 1000+
- Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study
- Minoxidil for Endocrine Therapy–Induced Alopecia in Women With Breast Cancer—Saint Agatha’s Blessing?
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Approaches to management of endocrine therapy–induced alopecia in breast cancer patients
- 51895 Interim Analysis of Platelet-Rich Plasma (PRP) Treatment for Endocrine Therapy-Induced Alopecia (EIA) and Permanent Chemotherapy-Induced Alopecia (pCIA) in Breast Cancer Patients: A Randomized Controlled Trial
- 0478 Outcomes of oral dutasteride and oral minoxidil for treating endocrine therapy-induced alopecia from breast cancer treatment: A case series
- Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study
- Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
- Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study
- A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil
- Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Alopecia in preexisting autoimmune thyroid disease in family medicine practice: can hyperprolactinemia induce hair loss? A case report
- RECENT DEVELOPMENTS IN ALOPECIAS
- Hypotrichosis and Alopecia
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Drugs and Androgenetic Alopecia: What to look out for
- Dermatological alterations induced by gynecological hormonal imbalances: Acne, hirsutism and alopecia
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in patients with breast cancer.
- Feline Dermatology
- HAIR LOSS IN WOMEN
- Hair Manifestations of Systemic Disease
- Diffuser Haarausfall und klinische Endokrinologie: Neue Erkenntnisse
- Medical and Surgical Hair Restoration
- [Hyperprolactinemia and hypophyseal hypothyroidism as cofactors in hirsutism and androgen-induced alopecia in women].
- Dermatological alterations induced by gynecological hormonal imbalances: Acne, hirsutism and alopecia
- Dermatological alterations induced by gynecological hormonal imbalances: Acne, hirsutism and alopecia